Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity RESAPP HEALTH LIMITED
ABN 51 094 468 318
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Dr Tony Keating |
Date of last notice | 7 July 2015 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should
be disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Not applicable |
Date of change | 10 November 2016 |
No. of securities held prior to change | 5,000,000 Options ($0.025; 2 July 2020) 5,000,000 Options ($0.05; 2 July 2020) 10,000,000 Options ($0.10; 2 July 2020) |
Class | Director Incentive Options |
Number acquired | 1,800,000 Tranche 1 Director Incentive Options exercisable at $0.45; expiring 10 November 2019; and 2,000,000 Tranche 2 Director Incentive Options exercisable at $0.75; expiring 10 November 2019 |
Number disposed | Nil |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director's Interest NoticeValue/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Director Incentive Options issued to provide an incentive and reward for Directors for their contributions to the Company as set out in the Company's Notice of Annual General Meeting. |
No. of securities held after change | 5,000,000 Options ($0.025; 2 July 2020) 5,000,000 Options ($0.05; 2 July 2020) 10,000,000 Options ($0.10; 2 July 2020) 1,800,000 Options ($0.45; 10 November 2019) 2,00,000 Options ($0.75; 10 November 2019) |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Director Incentive Options issued as approved by Shareholders at the Annual General Meeting held on 2 November 2016. |
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should
be disclosed in this part.
Detail of contract | Not applicable |
Nature of interest | Not applicable |
Name of registered holder (if issued securities) | Not applicable |
Date of change | Not applicable |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | Not applicable |
Interest acquired | Not applicable |
Interest disposed | Not applicable |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | Not applicable |
Interest after change | Not applicable |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Part 3 - +Closed period Appendix 3Y Change of Director's Interest NoticeWere the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | Not applicable |
If so, was prior written clearance provided to allow the trade to proceed during this period? | Not applicable |
If prior written clearance was provided, on what date was this provided? | Not applicable |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest NoticeRule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity RESAPP HEALTH LIMITED
ABN 51 094 468 318
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Dr Roger Aston |
Date of last notice | 7 July 2015 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should
be disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | - |
Date of change | 10 November 2016 |
No. of securities held prior to change | 8,437,500 Ordinary Fully Paid Shares (escrowed until 14 July 2017) 8,437,500 Performance Shares (escrowed until 14 July 2017) |
Class | Director Incentive Options |
Number acquired | 1,800,000 Tranche 1 Director Incentive Options exercisable at $0.45; expiring 10 November 2019; and 1,800,000 Tranche 2 Director Incentive Options exercisable at $0.75; expiring 10 November 2019 |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
ResApp Health Limited published this content on 11 November 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 November 2016 09:47:05 UTC.
Original documenthttp://www.resapphealth.com.au/wp-content/uploads/2016/11/1616742.pdf
Public permalinkhttp://www.publicnow.com/view/E5EE457E38A454D4D00B9898ED129A7451C40F1B